Prediction of hERG K+ blocking potency: Application of structural knowledge

SAR and QSAR in Environmental Research

Volumn 15, Issue 5-6, 2004, Pages 399-411

  Aptula, A O ^a   Cronin, M T D ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

hERG channel; Maximum diameter of molecules; MLR; QSAR; QT

Indexed keywords

COMPUTATIONAL CHEMISTRY; DRUG INTERACTIONS;

BLOCKINGS; HERG CHANNEL; K+ CHANNELS; MAXIMUM DIAMETER OF MOLECULE; MLR; PHYSICO-CHEMICALS; QSAR; QT; QT PROLONGATION; STRUCTURAL KNOWLEDGE;

MOLECULES;

EID: 8344284404     PISSN: 1062936X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10629360412331297353     Document Type: Conference Paper

References (36)

1. Russell, M.W. (1996) "The long QT syndromes", Prog. Pediatr. Cardiol. 6, 43-51.
2. Snyders, D.J. (1999) "Structure and function of cardiac potassium channels", Cardiovasc. Res. 42, 377-390.
3. Chiang, C-E. and Roden, D.M. (2000) "The long QT syndromes: genetic basis and clinical implications", J. Am. Coll. Cardiol. 36, 1-12.
4. Jervell, A. and Lange-Nielsen, F. (1957) "Congenital deaf-mutism, functional heart disease with prolongation of the QT interval and sudden death", Am. Heart J. 54, 59-68.
5. Romano, C., Gemme, G. and Pongiglione, R. (1963) "Aritmie cardiache rare dell'eta' pediatrica", Clin. Pediatr. 45, 656-683.
6. Ward, O.C. (1964) "A new familial cardiac syndrome in children", J. Ir. Med. Assoc. 54, 103-106.
7. Makkar, R.R., Fromm, B.S., Steinman, R.T., Meissner, M.D. and Lehmann, M.H. (1993) "Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs", J. Am. Med. Assoc. 270, 2590-2597.
8. MacNeil, D.J. (1997) "The side effect profile of class III antiarrhythmic drugs: focus on d,l-sotalol", Am. J. Cardiol. 80, 90-98.
9. Stahlmann, R. (2002) "Clinical toxicological aspects of fluoroquinolones", Toxicol. Lett. 127, 269-277.
10. Owens, R.C. and Ambrose, P.G. (2002) "Torsades de Pointes associated with fluoroquinolones", Pharmacotherapy 22, 663-672.
11. Anderson, M.E., Mazur, A., Yang, T. and Roden, D.M. (2001) "Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics", J. Pharmacol. Exp. Ther. 296, 806-810.
12. + channel HERG", Mol. Pharmacol. 59, 122-126.
13. Kongsamut, S., Kang, J., Chen, X-L., Roehr, J. and Rampe, D. (2002) "A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs", Eur. J. Pharmacol. 450, 37-41.
14. De Ponti, F., Poluzzi, E. and Montanaro, N. (2001) "Organising evidence on QT prolongation and occurrence of torsades de pointes with non-antiarrhythmic drugs: a call for consensus", Eur. J. Clin. Pharmacol. 57, 185-209.
15. Redfern, W.S., Carlsson, L., Davis, A.S., Lynch, W.G., MacKenzie, I., Palethorpe, S., Siegl, P.K.S., Strang, I., Sullivan, A.T., Wallis, R., Camm, A.J. and Hammond, T.G. (2003) "Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development", Cardiovasc. Res. 58, 32-45.
16. Gralinski, M.R. (2000) "The assessment of potential for QT interval prolongation with new pharmaceuticals. Impact on drug development", J. Pharmacol. Toxicol. 43, 91-99.
17. Ekins, S., Ring, B.J., Grace, J., McRobie-Belle, D.J. and Wrighton, S.A. (2000) "Present and future in vitro approaches for drug metabolism", J. Pharmacol. Toxicol. 44, 313-324.
18. Cronin, M.T.D. (2000) "Computational methods for the prediction of drug toxicity", Curr. Opin. Drug Discov. 3, 292-297.
19. + channel blockers", J. Med. Chem. 45, 3844-3853.
20. Pearlstein, R.A., Vaz, R.J., Kang, J., Chen, X-L., Preobrazhenskaya, M., Shchekotikhin, A.E., Korolev, A.M., Lysenkova, L.N., Miroshnikova, O.V., Hendrix, J. and Rampe, D. (2003) "Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches", Bioorg. Med. Chem. Lett. 13, 1829-1835.
21. Darpö, B. (2001) "Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes", Eur. Heart J. Suppl. 3, 70-80.
22. Cronin, M.T.D. (2005) "Toxicological information for use in predictive modelling: quality, sources, and databases", In: Helma, C., ed., Predictive Toxicology (Marcel Dekker, New York), in press.
23. + channels expressed in mammalian cell lines and Xenopus oocytes", J. Pharmacol. Toxicol. Method 48, 65-80.
24. + channel. A model for bad behavior", J. Med. Chem. 46, 2017-2022.
25. Sadowski, J. and Gasteiger, J. (1993) "From atoms and bonds to three-dimensional atomic coordinates: automatic model builders", Chem. Rev. 93, 2567-2581.
26. Dewar, M.J.S., Zoebisch, E.G., Healy, E.F. and Stewart, J.J.P. (1985) "AM1: a new general purpose quantum mechanical molecular model", J. Am. Chem. Soc. 107, 3902-3909.
27. Clark, T., Alex, A., Beck, B., Chandrasekhar, J., Gedeck, P., Horn, A., Hutter, M., Martin, B., Rauhut, G., Sauer, W., Schindler, T. and Steinke, T. Vamp 7.0, Oxford Molecular, The Medawar Centre, Oxford Science Park, SandfordonThames, Oxford OX4 4GA, United Kingdom, 1999/2000.
28. Schüürmann, G. (1998) "Ecotoxic modes of action of chemical substances", In: Schüürmann, G. and Market, B., eds, Ecotoxicology (John Wiley and Spektrum Akademischer Verlag, New York), pp 665-749.
29. Schultz, T.W. and Cronin, M.T.D. (2003) "Essential and desirable characteristics of ecotoxicity quantitative structure-activity relationships", Environ. Toxicol. Chem. 22, 599-607.
30. Tropsha, A., Gramatika, P. and Gombar, V. (2003) "The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models", QSAR Comb. Sci. 22, 69-77.
31. Cronin, M.T.D. (2004) "Predicting chemical toxicity and fate in humans and the environment - an introduction", In: Cronin, M.T.D. and Livingstone, D.J., eds, Predicting Chemical Toxicity and Fate (CRC Press, Boca Raton, FL), pp 3-13.
32. Cronin, M.T.D. and Schultz, T.W. (2003) "Pitfalls in QSAR", J. Mol. Struc. Theochem. 622, 39-51.
33. Cronin, M.T.D., Aptula, A.O., Duffy, J.C., Netzeva, T.I., Rowe, P.H., Valkova, I.V. and Schultz, T.W. (2002) "Comparative assessment of methods to develop QSARs for the prediction of the toxicity of phenols to Tetrahymena pyriformis", Chemosphere 49, 1201-1221.
34. Oprea, T.I., Davis, A.M., Teague, S.J. and Leeson, P.D. (2001) "Is there a difference between leads and drugs? A historical perspective", J. Chem. Inf. Comput. Sci. 41, 1308-1315.
35. Yoshida, F. and Topliss, J.G. (2000) "QSAR model for drug human oral bioavailability", J. Med. Chem. 43, 2575-2585.
36. Mitcheson, J.S., Chen, J. and Sanguinetti, M.C. (2000) "Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate", J. Gen. Physiol. 115, 229-239.